# Metabolomics Predict Therapy Response

> **NCT03736993** · NA · COMPLETED · sponsor: **Hasselt University** · enrollment: 160 (actual)

## Conditions studied

- NSCLC, Stage IIIA

## Interventions

- **OTHER:** Additional blood sampling

## Key facts

- **NCT ID:** NCT03736993
- **Lead sponsor:** Hasselt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-28
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2023-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03736993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03736993, "Metabolomics Predict Therapy Response". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03736993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*